SCHEMBL2055296

SCHEMBL2055296

COC(=O)CCN(CCCN(CCCN(CCC(=O)OC)CCC(=O)OC)CCCN(CCC(=O)OC)CCC(=O)OC)CCC(=O)OC

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.58
MEN1 O00255 2/20 0.58
TSHR P16473 4/20 0.56
KDM5A P29375 2/20 0.42
LMNA P02545 3/20 0.41
ALDH1A1 P00352 2/20 0.41
CA12 O43570 2/20 0.40
CA14 Q9ULX7 2/20 0.40
KDM4E B2RXH2 1/20 0.40
RECQL P46063 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
GLA P06280 1/20 0.39
HSD17B10 Q99714 2/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2055302 1.00 KMT2A (0.58) KMT2AMEN1TSHRKDM5ALMNA
SCHEMBL2055301 1.00 KMT2A (0.58) KMT2AMEN1TSHRKDM5ALMNA
SCHEMBL2055298 0.98 KMT2A (0.56) KMT2AMEN1TSHRKDM5ALMNA
SCHEMBL2055297 0.98 KMT2A (0.56) KMT2AMEN1TSHRKDM5ALMNA
SCHEMBL12450195 0.93 KMT2A (0.56) KMT2AMEN1TSHRKDM5ALMNA
SCHEMBL2055304 0.93 KMT2A (0.56) KMT2AMEN1TSHRKDM5ALMNA
SCHEMBL64783 0.93 KMT2A (0.65) KMT2AMEN1TSHRKDM5ALMNA
SCHEMBL15782634 0.92 MEN1 (0.55) KMT2AMEN1TSHRKDM5ALMNA
SCHEMBL12847700 0.92 KMT2A (0.50) KMT2AMEN1TSHRKDM5ALMNA
SCHEMBL12847856 0.92 MEN1 (0.55) KMT2AMEN1TSHRKDM5ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8889738-B2 Amido-amine polymer compositions GENZYME CORPORATION (US) 2014-11-18 US disclosed
US-8889738-B2 Amido-amine polymer compositions GENZYME CORPORATION (US) 2014-11-18 US disclosed
US-20120237470-A1 AMIDO-AMINE POLYMER COMPOSITIONS GENZYME CORPORATION (US) 2012-09-20 US disclosed
US-20120237470-A1 AMIDO-AMINE POLYMER COMPOSITIONS GENZYME CORPORATION (US) 2012-09-20 US disclosed
US-8163799-B2 Amido-amine polymer compositions GENZYME CORPORATION (US) 2012-04-24 US disclosed
US-8163799-B2 Amido-amine polymer compositions GENZYME CORPORATION (US) 2012-04-24 US disclosed
US-20100093857-A1 AMIDO-AMINE POLYMER COMPOSITIONS GENZYME CORPORATION (US) 2010-04-15 US disclosed
US-20100093857-A1 AMIDO-AMINE POLYMER COMPOSITIONS GENZYME CORPORATION (US) 2010-04-15 US disclosed
WO-2008076242-A1 AMIDO-AMINE POLYMER COMPOSITIONS GENZYME CORPORATION (US) 2008-06-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100093857-A1 AMIDO-AMINE POLYMER COMPOSITIONS PHPT1, PAM, PTH1R KMT2A 1852/4885MEN1 127/4885TSHR 988/4885
US-20120237470-A1 AMIDO-AMINE POLYMER COMPOSITIONS PHPT1, PAM, PTH1R KMT2A 1852/4885MEN1 127/4885TSHR 988/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.